Status:

COMPLETED

Study of Immediate Start of Progestin Contraceptives in Medical Abortion

Lead Sponsor:

Gynuity Health Projects

Conditions:

Contraception

Eligibility:

FEMALE

Phase:

PHASE4

Brief Summary

This study will compare immediate to post-abortion start of two progestin-based contraceptives (DMPA and etonorgestrel implants) among women having first trimester medical abortion who wish to use tha...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Women having medical abortion desiring progestin-based contraceptives (injectables or implants)

Exclusion

    Key Trial Info

    Start Date :

    July 1 2013

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 1 2015

    Estimated Enrollment :

    937 Patients enrolled

    Trial Details

    Trial ID

    NCT01902485

    Start Date

    July 1 2013

    End Date

    December 1 2015

    Last Update

    March 4 2016

    Active Locations (8)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 2 (8 locations)

    1

    Planned Parenthood of the Pacific Southwest

    Chula Vista, California, United States

    2

    Planned Parenthood Northern California

    Eureka, California, United States

    3

    Planned Parenthood of Southern New England

    Stamford, Connecticut, United States

    4

    Bayview Medical Center

    Baltimore, Maryland, United States